tbuckley/cabot-search huggingface dataset:
Impact of Disease Burden, CAR-T Expansion, and Mononuclear Cell Recovery on Overall Response and Duration of Response in Zuma-3 Pivotal Study
Authors: Sabina Adhikary, Colleen Schweitzer, Fang Sun, Daqin Mao, Sharon Mu, Srikanth Mannem, Rubina Siddiqi, Tsveta Hadjivassileva, Rita Damico Khalid, Rhine Shen
Journal: Blood (2024)
Voltage-Dependent Anion Channel 2 Controls Mitochondrial Priming through BAK Stabilization in Multiple Myeloma
Authors: Ophélie Champion, Sophie Maiga, Christelle Dousset, Agnès Aubry, Céline Bellanger, François Guillonneau, Jose Antonio Moreno, Ohyun Kwon, Philippe Moreau, David Chiron, Catherine Pellat-Deceunynck, Cyrille Touzeau, Patricia Gomez-Bougie
Journal: Blood (2024)
Factors Associated with Palliative Care Utilization Among Patients with Post-Transplant Lymphoproliferative Disease. a Retrospective Analysis of the National Inpatient Sample Database
Authors: Hilary A Elom, Tarfa Verinumbe, Elvis Obomanu, Hasiya Yusuf, Colton Frisco Jones, Monika Kulasekaran
Journal: Blood (2024)
Discovery and Immunotherapeutic Targeting of the Tumor-Specific Target LAMP5 in Acute Myeloid Leukemia
Authors: Grace Hawkins, Danielle Kirkey, Nika Panahi, Melia Blankenfeld, Isabel Lira, Tiffany Hylkema, Cyd McKay, Christina Root, Jack H. Peplinski, Logan K. Wallace, Rhonda E. Ries, Laura Pardo, Michael R. Loken, Soheil Meshinchi
Journal: Blood (2024)
Establishing a Distinct Cytokine Signature for Multiple Myeloma Using Bone Marrow RNA and Peripheral Blood Cell-Free RNA (cfRNA)
Authors: Maher Albitar, Hong Zhang, Sally Agersborg, Ahmad Charifa, Pooja Phull, Noa Biran, David H. Vesole, Harsh Parmar, Andrew L Pecora, Andrew Ip, Andre Goy, David S. Siegel
Journal: Blood (2024)
Rheological Comparison of Red Cells from Individuals with SCD Treated with Gene Therapy, Haploidentical Transplantation or Hydroxyurea
Authors: Britney Hernandez, Ashwin P. Patel, Erica N Evans, Jordan Zgodny, Stephen Gottschalk, Brandon M Triplett, Serena De Vita, Kirby Wallace, David C Shyr, Elizabeth O Stenger, Suhag Parikh, Akshay Sharma, Vivien Sheehan
Journal: Blood (2024)
Comprehensive (Epi)Genetic Tumor Characterization and Disease Follow-Up in Multiple Myeloma Using Blood-Derived Cell-Free DNA
Authors: Robbe Heestermans, Catharina Olsen, Jana Succari, Shervine Ameli, Toon Janssen, Ann De Becker, Isabelle Vande Broek, Marleen Bakkus, Rik Schots, Elke De Bruyne, Ivan Van Riet
Journal: Blood (2024)
Immunotherapy with pVAX14 Nucleic Acid in Combination with All-Trans Retinoic Acid (ATRA) in an Acute Promyelocytic Leukemia (APL) Mouse Model Activates Cytotoxic T-Cells and Enhances Immune Responses: A Strategy for Turning “Cold” Tumors “Hot”
Authors: Rose Ann Padua, Satyananda Patel, James Smith, Dr Omidvar, Nilgun Tekin, Fabien Guidez, Mathieu Chiquet, Niclas Setterblad, Ken I Mills, Marika PLA, Patricia Krief, Thierry Huet, Christine Chomienne, Pierre Fenaux
Journal: Blood (2024)
JAK Inhibition Results in Aggressive Cutaneous Squamous Cell Carcinoma through MAPK Pathway Activation and Shapes the Tumor Immune Microenvironment to Create Novel Therapeutic Opportunities
Authors: Helene Pasquer, Valeria Bisio, Antoine Forget, Maxime Battistella, Barouyr Baroudjian, Raphael Marie, Emmanuelle Latour, Cecile Culeux, Lea Pelissier, Blandine Roux, Khansa Saadallah, Matthieu Duchmann, Thierry Tchenio, Abdellah Tebani, Amandine Gouverneur, Fanelie Jouenne, Jerome Lambert, Isabelle Madelaine, Lionel Ades, Emmanuel Raffoux, Pernelle Noize, Bruno Cassinat, Soumeya Bekri, Juliette Soret-Dulphy, Samia Mourah, Camille Lobry, Alexandre Puissant, Jean-Jacques Kiladjian, Nicolas Dulphy, Celeste Lebbe, Lina Benajiba
Journal: Blood (2024)
Dual Bclxl and BCL2 Inhibition with Navitoclax (NAV), Venetoclax (VEN), and Decitabine (DEC) for Advanced Myeloid Neoplasms (MN): Safety and Biological Activity in a Phase 1 Study
Authors: Evan C. Chen, Yiwen Liu, Hayden L. Bell, Ilene A. Galinsky, Marlise R. Luskin, Eric S. Winer, Maximilian Stahl, Rahul Vedula, Virginia O. Volpe, Daniel J. DeAngelo, Karen Quillen, Jeremy Ryan, Emma-Jayne Minihane, Matthew Hersch, Rebecca Leonard, Donna S. Neuberg, Richard M. Stone, Anthony G. Letai, Andrew A. Lane, Jacqueline S. Garcia
Journal: Blood (2024)
Impact of Pre-Treatment Liver-Related Factors on Clinical Outcomes after CAR T-Cell Therapy for Lymphoma
Authors: Anath Lionel, Sushanth Gouni, Lei Feng, Charles Gaulin, Amrit S. Gonugunta, Turcin Saridogan, Michelly Abreu, Jaimole Varghese, Karla Ow, Minifrida Santiago, Ajlan Al Zaki, Sherry Adkins, Amy A. Ayers, Misha Hawkins, Partow Kebriaei, Elizabeth J. Shpall, Swaminathan P Iyer, Preetesh Jain, Michael Wang, Christopher R. Flowers, Jeremy Ramdial, Loretta Nastoupil, Jason R. Westin, Paolo Strati, Sattva S. Neelapu, Deyali Chatterjee, Sairah Ahmed
Journal: Blood (2024)
Soluble BCMA As a Surrogate Biomarker for Tumor Burden in Multiple Myeloma: Correlations with Various Biomarkers and Treatment Responses
Authors: Rikako Tabata, Mitsuaki Oura, Daisuke Ikeda, Shuichi Aikawa, Chiho Misono, Fuminari Fujii, Hajime Sakuma, Masanori Toho, Atsushi Uehara, Kentaro Narita, Masami Takeuchi, Tomohisa Watari, Yoshihito Otsuka, Kosei Matsue
Journal: Blood (2024)
Preliminary Results of a Phase 1, Dose-Escalation Study of PRT2527, a Potent and Highly Selective CDK9 Inhibitor, As Monotherapy and in Combination with Zanubrutinib in Patients with Relapsed/Refractory Lymphoid Malignancies
Authors: Katharine L. Lewis, Wojciech Jurczak, Gareth P. Gregory, Constantine S. Tam, Won Seog Kim, Eliza A. Hawkes, Franck Morschhauser, Sarit E. Assouline, Geoffrey Shouse, Petra Langerbeins, Monica Tani, Young Rok Do, Bruce D. Cheson, Catherine S. Diefenbach, Craig A. Portell, Jennifer Xavier, Muhtarjan Osman, Siminder K. Atwal, Wan-Jen Hong, Clémentine Sarkozy
Journal: Blood (2024)
ASC4REAL: Efficacy and Tolerability Comparison between Ascembl Study, a Phase 3 Randomized Clinical Trial (RCT), and Consolidated Real-World (RW) Evidence with Asciminib in CML Patients Beyond 2 TKIs
Authors: Anchit Khanna, Hannah Small, Dhamend Lutchman, Rafael Erlich, Gabriel Marquez, Daisy Yang, Kejal Jadhav
Journal: Blood (2024)
Preliminary Data on the Efficacy and Safety of Orelabrutinib Combined with Rituximab and Methotrexate (ORM Regimen) As First-Line Treatment for Primary Central Nervous System Lymphoma, and the Exploration of Cerebrospinal Fluid Ctdna Dynamic Monitoring
Authors: Lixia Sheng, Guifang Ouyang, Yanli Lai, Sheng Nie, Di Wang, Shanhao Tang, Yuning Pan, Kaihong Xu, Yongcheng Sun, Ping Zhang, Binbin Lai, Lieguang Chen
Journal: Blood (2024)
<i>Real-World Outcomes of Acute Myeloid Leukemia Patients Undergoing Treatment with Tyrosine Kinase Inhibitor (TKI) Therapy Targeting FLT3, IDH1, or IDH2</i>
Authors: Manuel Espinoza-Gutarra, Brooke Jarrett, Xiaoliang (Wendy) Wang, Anosheh Afghahi, Sejong Bae
Journal: Blood (2024)
A CD38xCD28 Costimulatory Bispecific Antibody Demonstrates Potent Preclinical Combinatorial Activity with a BCMAxCD3 T Cell-Engager
Authors: Kara Olson, David DiLillo, Olga Sineshchekova, Katja Mohrs, Craig McCarthy, Hassan Ahmed, Sahar Rizvi, Steven Quatela, Elizabeth Navarro, Cuiyan Lin, Amanda Dorvilliers, Glenn S. Kroog, Karen Rodriguez Lorenc, Erica Ullman, Aynur Hermann, Eric Smith, Jessica Kirshner, William Olson, John Lin
Journal: Blood (2024)
Incidence and Time to Diagnosis of Secondary Malignancies in Patients with Hairy Cell Leukemia: A Systematic Review and Meta-Analysis
Authors: Manasawee Tanariyakul, Sakditad Saowapa, Akihiro Miyashita, Chalothorn Wannaphut, Panisara Fangsaard, Kensuke Takaoka
Journal: Blood (2024)
Phase 2 Study Using Minimal Residual Disease-Driven Adaptive Strategy in Newly Diagnosed Multiple Myeloma with Upfront Daratumumab-Based Therapy - First Report from the Maestro Trial
Authors: J Christine Ye, Philip Boonstra, Erica L. Campagnaro, Matthew Pianko, Andrew Kin, Larry D Anderson, Brea Lipe, Moshe Talpaz, Jeffrey A. Zonder
Journal: Blood (2024)
Pembrolizumab in Children, Adolescents, and Young Adults with High-Risk Classic Hodgkin Lymphoma (cHL) with Slow Early Response to Front-Line Chemotherapy: Updated Results from the Phase 2 Keynote-667 Study
Authors: Christine Mauz-Koerholz, Luciana Vinti, Stephen Daw, Antony Ceraulo, Gerard Michel, Michaela Cepelova, Lorena Valero-Arrese, Franca Fagioli, Stéphane Ducassou, Salvatore Buffardi, Thierry Leblanc, Bradford S Hoppe, Frank G. Keller, Kara M. Kelly, Lisa Giulino Roth, Judith Landman-Parker, Juan Shen, Pallavi Pillai, Rushdia Yusuf, Auke Beishuizen
Journal: Blood (2024)
Hyperbaric Oxygen (HBO) Effects on Blood Count Recovery and Post Transplant Outcomes Following High-Dose Therapy and Autologous HSPC Transplantation for Multiple Myeloma: Final Analysis of the Multicenter Phase II Randomized Clinical Trial
Authors: Leyla O. Shune, Ayman Qasrawi, Gerhard C Hildebrandt, Eric J Huselton, Howard Langstein, Dennis Allin, Kaitlyn Burrows, Andrea M Baran, Jane L. Liesveld, Neil Blumberg, Brea Lipe, Andrew G Evans, Derick R Peterson, Omar Aljitawi
Journal: Blood (2024)
Modified Delphi Process to Develop Best Practice Recommendations for Myelofibrosis Management in Routine Clinical Practice in the Asia-Pacific Region (The APAC-MF Alliance)
Authors: Harinder Gill, Chul Won Choi, Hein Than, Hsin-An Hou, Chul Won Jung, Yok-Lam Kwong, Garret M. K. Leung, Melissa G. M. Ooi, Ponlapat Rojnuckarin, David M. Ross, Lee-Yung Shih, Katsuto Takenaka, Winnie Z. Y. Teo, Keita Kirito
Journal: Blood (2024)
Phase II Trial of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in High-Risk Smoldering Multiple Myeloma
Authors: Omar Nadeem, Sophie Magidson, Robert A. Redd, Jacob P. Laubach, Clifton C. Mo, Elizabeth K. O'Donnell, Adam S. Sperling, Monique A. Hartley-Brown, Shonali Midha, Yuxin Liu, Frances Arters, Marjorie Marto, Christine Davie, Caroline Ricciardi, Dechen Choden, Ashlee Strutevant, Jillian Alberti, Amy Goguen, Michael Constantine, Pedro Sanz-Altamira, Lorenzo Trippa, Nikhil C. Munshi, Kenneth C. Anderson, Paul G. Richardson, Irene Ghobrial
Journal: Blood (2024)
Multiple Myeloma Persister Cells Surviving Bispecific Antibodies and CAR-T Cells Exhibit New CD45+ Expression
Authors: Alana L. Keller, Zachary J. Walker, Sarah E. Parzych, Tanisha N. Medha, Lauren T. Reiman, Peter A. Forsberg, Jeremy Rahkola, Meher P. Boorgula, Daniel W. Sherbenou
Journal: Blood (2024)
A Comparative Study of [18f]FDG PET and MRI for Evaluating Treatment Response in Primary CNS Lymphoma Patients Undergoing High-Dose Methotrexate Therapy
Authors: Minyoung Oh, Hyungwoo Cho, Ji Eun Park, Ho Sung Kim, Heounjeong Go, Chan-Sik Park, Sang-wook Lee, Sang Woo Song, Young-Hoon Kim, Young Hyun Cho, Seok Ho Hong, Jeong Hoon Kim, Dong Yun Lee, Jin-Sook Ryu, Dok Hyun Yoon, Jae Seung Kim
Journal: Blood (2024)
Perceptions of Clinical Trials and Factors Influencing Trial Participation Among Hispanic Patients with Non-Hodgkin Lymphoma
Authors: Alexis Romero, Sophia Nguyen, Amy A. Ayers, Minxing Chen, Clark R. Andersen, Rebecca Yzquierdo, Adiya Rahman, Lauren Johnson, Tiffany Vickers, Zeinab Wafi, Lorna McNeill, James R. Cerhan, Christopher R. Flowers, Chijioke Nze
Journal: Blood (2024)
Increased Rates of MRD Conversion from Positive (+ve) to Negative (-ve) Following ASCT Compared to Chemotherapy Consolidation in Newly Diagnosed Multiple Myeloma Is Prognostic for Improved Progression Free Survival: Dynamic MRD Assessment in the UK-MRA Cardamon Trial
Authors: Ceri Bygrave, William Wilson, Rakesh Popat, Marquita Camilleri, Karthik Ramasamy, Matthew Streetly, Michael A. Chapman, Ruth M de Tute, Selina J Chavda, Elizabeth H. Phillips, Maria del Mar Cuadrado, Fuad Fananapazir, Charlotte Tyson, Sumaiya Kamora, James D. Cavenagh, Roger G Owen, Kwee Yong
Journal: Blood (2024)
Initial Results from the Frailty-Stratified, Randomised Controlled Bayesian Adaptive Trial of Bortezomib Versus Lenalidomide in Transplant Ineligible Myeloma (TI-NDMM) - the FRAIL-M Study (AMaRC 19-01; ALLG MM22)
Authors: Sueh-Li Lim, John Reynolds, Lucy Pemberton, Tricia Wright, Sophie Hyesuk Lee, Peter Mollee, Anita C Shetty, Helen Weston, Nina Byard, Khoa Le, Zoe K McQuilten, Hang Quach, Andrew Spencer
Journal: Blood (2024)
Outcomes of Patients Intended for Autologous Stem Cell Transplantation with CT-Based Partial Response but PET-Based Deauville Score of 5 after Salvage Chemotherapy
Authors: Chathuri Abeyakoon, Vanessa Murad, Ho-Young Yhim, Inna Gong, John Kuruvilla, Michael Crump, Anca Prica, Vishal Kukreti, Sita D. Bhella, Christine I Chen, Chloe Yang, Richard Tsang, David Hodgson, Danielle Rodin, Nauman Malik, Woodrow Wells, Ur Metser, Robert Kridel, Abi Vijenthira
Journal: Blood (2024)
Final Analysis of a Phase I Study of Escalating Doses of the BCL-2 Inhibitor Venetoclax in Combination with Daunorubcin/Cytarabine Induction and High Dose Cytarabine Consolidation in Previously Untreated Adults with Acute Myeloid Leukemia
Authors: Richard M Stone, Daniel J. DeAngelo, Anthony G. Letai, Ilene A. Galinsky, Howard Weiner, Austen Halpin, Lexi Noyes, Hunter Smith, Carter Lombardi, Rebecca Leonard, Geoffrey Fell, Yael Flammand, Jeremy Ryan, Marina Konopleva, Martha Wadleigh, Maximilian Stahl, Evan Chen, Virginia O. Volpe, Eric S. Winer, Jacqueline S. Garcia, Marlise R. Luskin, Anand Ashwin Patel
Journal: Blood (2024)
MagnetisMM-9: Efficacy and Safety of Step-up Priming Doses and Longer Dosing Intervals of Elranatamab (ELRA) in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)
Authors: Matthew Pianko, Charlotte Pawlyn, Shang-Yi Huang, Tadao Ishida, Douglas W Sborov, Shinsuke Iida, Aravind Ramakrishnan, Reuben Benjamin, Rakesh Popat, Steven Schuster, Junya Kuroda, Chia-Jen Liu, Anne Philippe, Umberto Conte, Fangxin Hong, Erik Vandendries, Rafael Fonseca
Journal: Blood (2024)
Vincristine Dose Adjustments in Acute Lymphoblastic Leukemia: Impact on Treatment Outcomes and Neuropathy
Authors: Ivan Arnaud-Borboa, Vania Yael Aguirre Muñoz, Mariem Pulido, Fausto A Rios-Olais, Juan Luis Ontiveros-Austria, Roberta Demichelis
Journal: Blood (2024)
Impact of the Diagnosis-to-Treatment Interval (DTI) on Outcomes in Older Adults with Diffuse Large B-Cell Lymphoma (DLBCL) Treated in the Real-World Setting
Authors: Paul A. Hamlin, Pallawi Torka, Eric Hansen, Andrew J. Belli, Jacob Ambrose, Christina M. Zettler, Laura L. Fernandes, Stephanie Wiley, Brittney Perry, Ching-Kun Wang
Journal: Blood (2024)
Evaluation of Methotrexate Pharmacogenomic Variants to Predict Acute Neurotoxicity in Children with Acute Lymphoblastic Leukemia
Authors: Austin L Brown, Rachel Harris, Olga A Taylor, Mark Zobeck, Melanie Brooke Bernhardt, Maria Monica Monica Gramatges, Ashley Chavana, Alanna Morrison, Kathleen Ludwig, Laura J. Klesse, Kenneth Matthew Heym, Timothy Griffin, Rodrigo Erana, Juan C. Bernini, Han Chen, Bing Yu, Melissa A. Richard, Philip J Lupo, Karen R Rabin, Michael E. Scheurer
Journal: Blood (2024)
Real-World (RW) Outcomes for Brexucabtagene Autoleucel (Brexu-Cel) Treatment in Patients (Pts) with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL) By High-Risk Features and Prior Treatments: Updated Evidence from the CIBMTR® Registry
Authors: Kitsada Wudhikarn, Evandro Bezerra, Yang Yang, Miguel-Angel Perales, Nitin Jain, Usama Gergis, Ahmed Aribi, LaQuisa Hill, Jessica T. Leonard, Forat Lutfi, Soyoung Kim, Matthew Bye, Zhen-Huan Hu, Hai-Lin Wang, Zhong-Cheng Luo, Rubina Siddiqi, Rita Damico Khalid, Jessica Speiser, Marcelo C. Pasquini, Partow Kebriaei, Lori Muffly
Journal: Blood (2024)
High-Risk Multiple Myeloma in Benefit (IFM 2020-05) Phase 3 Randomized Study of Isatuximab (Isa) Plus Lenalidomide and Dexamethasone (Rd) with Bortezomib Versus Isard in Patients with Newly Diagnosed Transplant Ineligible Multiple Myeloma (NDMM TI)
Authors: Jill Corre, Jérôme Lambert, Arthur Bobin, Salomon Manier, Aurore Perrot, Lionel Karlin, Murielle Roussel, Noemie Bigot, Omar Benbrahim, Olivier Thierry Allangba, Philippe Rey, Veronique Dorvaux, Marguerite Vignon, Virginie Roland, Reda Garidi, Jean-Noel Bastie, Marie-Lorraine Chrétien, Sophie Godet, Lydia Montes, Brieuc Cherel, Thomas Chalopin, Borhane Slama, Kamel Laribi, Claire Dingremont, Christophe Roul, Valentine Richez, Clara Mariette, Sophie Rigaudeau, Claire Calmettes, Mamoun Dib, Mourad Tiab, Laure Vincent, Jacques Delaunay, Jean Pierre Marolleau, Pascal Godmer, Laurent Frenzel, Ronan Le Calloch, Emilie Chalayer, Helene Gardeney, Margaret Macro, Bruno Royer, Olivier Decaux, Bertrand Arnulf, Karim Belhadj Merzoug, Cyrille Touzeau, Mohamad Mohty, Aurelie Gontier, Amine Kasmi, Philippe Moreau, Thierry Facon, Herve Avet Loiseau, Cyrille Hulin, Xavier Leleu
Journal: Blood (2024)
Phase 1 Trial of Navitoclax/Venetoclax/Decitabine Combination in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
Authors: Anthony S. Stein, Jianying Zhang, Lucy Y. Ghoda, Marjorie Robbins, Cindy Croslin, Banafsheh Sinaki, Ahmed Aribi, Amanda Blackmon, Hoda Pourhassan, Brian J. Ball, Ibrahim Aldoss, Ryotaro Nakamura, MHD Monzr M. Al Malki, Karamjeet S Sandhu, Guido Marcucci
Journal: Blood (2024)
Results from a Clinical Study of the All-Oral Regimen of CC-486 (Oral Azacitidine) and Venetoclax for Newly Diagnosed and Relapsed and Refractory Acute Myeloid Leukemia
Authors: Maria L Amaya, Christine M. McMahon, Marc Schwartz, Jonathan Gutman, Andrew Kent, Diana Abbott, Connor Sohalski, Jessica Dell-Martin, Ayele Belachew, Brett M Stevens, Craig T Jordan, Daniel A Pollyea
Journal: Blood (2024)
Impact of <i>MYC</i> Alterations in De Novo and Transformed Large B-Cell Lymphoma: An Italian Single Center Experience
Authors: Chiara Pagani, Alessandro Re, Simone Maifredi, Angela Passi, Rosa Daffini, Antonella Anastasia, Marina Motta, Samuele Bagnasco, Erika Borlenghi, Alessia Pantaleo, Chiara Aquilina, Alessandra Tucci
Journal: Blood (2024)
Risk Factors for Cytokine Release Syndrome in Patients Receiving Bispecific Antibodies for B-Cell Lymphoma: A Single-Center, Retrospective Cohort Study
Authors: XI Yang, Iman Ahmed, Victoria Nachar, Shannon A. Carty, Ryan A. Wilcox, Jonathan Weiss, Dahlia Sano, Tycel J. Phillips, Yasmin H. Karimi
Journal: Blood (2024)
A Systematic Literature Review of Real-World Outcomes Following Anti-Interleukin-5 and Anti-Interleukin-5 Receptor Alpha Treatment for Hypereosinophilic Syndrome: Case Reports and Cohort Studies
Authors: Priya Jain, Jennifer Rowell, Chris Edmonds, Michael Stokes, Ning Ding, Stephanie Yanjing Chen
Journal: Blood (2024)
An Evaluation of Andexanet Alfa v. Standard of Care for Reversal of Doac-Induced Intracranial Hemorrhage - a Systematic Review and Meta-Analysis
Authors: Alexander J Xiang, Sarah Sadafi, Rachael Principato, Asim Shaikh, Mehrad Nowrouzi, Allen Li, Ali Eshaghpour, Mark A. Crowther
Journal: Blood (2024)
Higher Teclistamab Step-up Dosing in Patients with Relapsed or Refractory Multiple Myeloma (RRMM): Results from the Majestec-1 Trial
Authors: Jeffrey V Matous, Niels W.C.J. van de Donk, Albert Oriol, Alfred L. Garfall, Paula Rodríguez-Otero, Thomas Chalopin, Laura Rosinol Dachs, Katarina Uttervall, Maria- Victoria Mateos, Danielle Trancucci, Natalia Quijano Cardé, Caroline Hodin, Tara Stephenson, Athena Zuppa, Katherine Chastain, Lionel Karlin
Journal: Blood (2024)
Final Results of a Phase II Study of Uproleselan Combined with Cladribine and Low-Dose Cytarabine for Patients with Treated Secondary Acute Myeloid Leukemia (ts-AML)
Authors: Caitlin R Rausch, Emmanuel Almanza-Huante, Wei-Ying Jen, Guillermo Montalban-Bravo, Farhad Ravandi, Kelly S. Chien, Nicholas J. Short, Naval Daver, Courtney D. DiNardo, Abhishek Maiti, Joseph E. Jabbour, Ghayas C. Issa, Guillermo Garcia-Manero, Hagop M. Kantarjian, Tapan M. Kadia
Journal: Blood (2024)
Low Intensity Daratumumab to Treat Rersistent/Recurrent Minimal Residual Disease in Multiple Myeloma
Authors: Lingzhi Yan, Xiaolan Shi, Jing Wang, Song Jin, Ying Yao, Panfeng Wang, Jingjing Shang, Yingying Zhai, Shuang Yan, Yun Xu, Jiajia Meng, Weiqin Yao, Xiao Ma, Chengcheng Fu, Depei Wu
Journal: Blood (2024)
A Multicenter, Prospective, Observational Study of Pola-R-CHP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (POLASTAR): A Preliminary Analysis
Authors: Hirohiko Shibayama, Atsushi Satake, Kohta Miyawaki, Yuki Fujiwara, Shuichi Ota, Tsuyoshi Muta, Shinya Rai, Hisashi Tsurumi, Ritsuro Suzuki, Takaaki Miyake, Hideki Goto, Noriko Fukuhara, Mamiko Sakata-Yanagimoto, Koji Izutsu, Momoko Nishikori, Takahiro Kumode, Daisuke Ennishi, Takayuki Shimose, Naoki Inubashiri, Itaru Matsumura, Koichi Akashi, Koji Kato
Journal: Blood (2024)
BL-M11D1, a Novel CD33 Antibody-Drug Conjugate (ADC), in Patients with Relapsed/ Refractory Acute Myeloid Leukemia: Initial Results from First-in-Human Phase 1 Study
Authors: Lin Song, Junyuan Qi, Zhenzhen Wang, Xiaoxia Li, Sa Xiao, Hai Zhu, Yi Zhu, Jianxiang Wang
Journal: Blood (2024)
Trends and Outcomes of Hematopoietic Stem Cell Transplantation for Malignant Lymphoma in Japan between 2006 and 2021
Authors: Ayako Muramatsu, Ayumi Fujimoto, Koji Izutsu, Tsutomu Kobayashi, Takahiro Fukuda, Go Yamamoto, Yasufumi Uehara, Masashi Sawa, Nobuhiro Hiramoto, Tsuyoshi Muta, Keisuke Kataoka, Yoshinobu Kanda, Jun Ishikawa, Makoto Onizuka, Koji Kawamura, Junya Kanda, Yoshiko Atsuta, Junya Kuroda, Shinichi Kako, Ritsuro Suzuki
Journal: Blood (2024)
Anti-CD3/B-Cell Maturation Antigen Bispecific Antibody CM336 in Relapsed/Refractory Multiple Myeloma: An Open-Label, Phase I/II Study
Authors: Gang An, Zhongxia Huang, Aibin Liang, Baijun Fang, Hongmei Jing, Lu-Gui Qiu
Journal: Blood (2024)
Gallic Acid Enhances GVL Effects of T Cells without Exacerbating Gvhd after Hematopoietic Stem Cell Transplantation
Authors: Qianqian Huang, Xinya Jiang, Bixia Wang, Zhigui Wu, Fangqing Zhang, Huidong Guo, Xiao Jun Huang
Journal: Blood (2024)
A Comparison of Different Comorbidity Indices in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT): Comprehensibility Vs Simplicity Vs Objectivity
Authors: Lorenzo Iovino, Ningxin Ma, Chris Davis, Linda M Glockling, Sophie L Martin, Filippo Milano, Jordan Gauthier, Naveed Ali, Ted Gooley, Qian Vicky Wu, Mohamed Sorror
Journal: Blood (2024)
Neuronal-Glial and Immune Microenvironment Signatures Show Prognostic Effects in Primary CNS Lymphoma
Authors: Zijun Y. Xu-Monette, Xiaoxiao Wang, Govind Bhagat, Alexandar Tzankov, Qingyan Au, Carlo Visco, Harry Nunns, Alessandro La Ferlita, Lalit Sehgal, April Chiu, Heounjeong Go, Anamarija M. Perry, Huilan Rao, Mina Xu, Qiongli Zhai, Yafei Wang, Shi Wang, Wenbin Qian, Maurilio Ponzoni, Wen Shuai, Bangchen Wang, Sergio Pina-Oviedo, Luis Carrillo, Kelly Au, Santiago Montes-Moreno, Karen Dybkaer, Zenggang Pan, William Choi, Michael Møller, Luigi Racioppi, Xiaohui Zhang, Jinming Song, Shanxiang Zhang, Youli Zu, Joo Y. Song, Eric D. Hsi, Fenghuang Zhan, Benjamin M. Parsons, Aliyah R. Sohani, Weina Chen, Fabio Iwamoto, Jeremy S. Abramson, Bing Xu, Yong Li, Ken H. Young
Journal: Blood (2024)
A Phase 2 Study of CART-ASCT-CART2 Sandwich Regimen Treatment in Patients with Primary Plasma Cell Leukemia
Authors: Jingyu Xu, Shuaishuai Zhang, Wenqiang Yan, Yuntong Liu, Rui Lyu, Chenxing DU, Weiwei Sui, Lu-Gui Qiu, Gang An
Journal: Blood (2024)
Evaluating the Clinical Utility of Real-Time Comprehensive Whole Exome Sequencing and RNA-Seq for Patients with Diffuse Large B-Cell Lymphoma
Authors: Dai Chihara, Kumudha Balakrishnan, Gita Masand, Robert Andrew Harkins, Neha Akkad, Anna Novokreshchenova, Alexander Bagaev, Nikita Kotlov, Ekaterina Postovalova, Eduardo Shugaev-Mendosa, Yuliya Gracheva, Kelley Lauziere, Leznath Kaneunyenye, Brianna McKenna, Amber Berlinski, McKenna Walsh, Linnea Larson, Mariam Kotsinyan, Anna Samokhina, Sheila T Yong, Krystle Nomie, Nathan H. Fowler, Christopher R. Flowers, Jason R. Westin
Journal: Blood (2024)
Prevalence and Clinical Implications of Germline Variants in Multiple Myeloma Patients
Authors: Tadeusz Kubicki, Kaina Millan, Anna Pula, Henry Raeder, Quinn Hauck, Manoj Bhagwat, Jude Barton, Eyitayo Awe, Soma Das, Daniela Del Gaudio, Sulin Wu, Frank Wen, Jennifer H Cooperrider, Benjamin A Derman, Andrzej J Jakubowiak, Michael W Drazer
Journal: Blood (2024)